Shots: CI Comments/ Implications: Commencing this partnership between AbbVie and TeneoOne,...
Shots: The P-III CLL14 Study involves assessing of Venclexta/Venclyxto + Gazyva/Gazyvaro v...
Shots: The agreement involves assessing safety, efficacy and tolerability of BeiGene’...
Shots: The partial clinical hold follows P-III BELLINI trial (M14-031) study results asses...
Shots: CI Comments/ Implications: Roche’s interest in acquiring Spark was fueled lar...
Shots: BMS acquires Celgene, in all stock transaction for $74B. Celgene to receive $50/sha...